NEW YORK (GenomeWeb) - Biocept reported after the close of the market Thursday that its first quarter revenues increased 47 percent year over year, primarily due to growing commercial test volume.

For the three months ended March 31, the company's total revenues rose to $221,369 from $150,002 the prior year's quarter.

The liquid biopsy firm said it tested 810 billable samples during the first quarter of 2016, up from 289 billable cases during the first quarter of 2015.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.